POTENTIAL ROLE OF SYZYGIUM CUMINI EXTRACT SUPPRESSING A549 LUNG CARCINOMA CELL GROWTH

Authors

  • Shrasti Singh, Dr. Nalini K. Sahoo, Mr. Akhilesh Kumar

Keywords:

A549 Cell Line, Human Lung Adenocarcinoma, Lung Cancer In Vitro, Syzygium Cumini Extract, Apoptosis in Cancer Cells

Abstract

Background: Lung cancer remains the leading cause of cancerrelated mortality worldwide, with limited therapeutic options due to
multidrug resistance and severe toxicity associated with conventionalchemotherapy. Syzygium cumini (Myrtaceae), traditionally used in Ayurvedic medicine, contains bioactive phytochemicals with reportedantitumor properties.

References

Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers

in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10.3322/caac.21660

Rami-Porta R, Asamura H, Travis WD, Rusch VW. Lung cancer—major changes in the American Joint Committee on Cancer eighth edition cancer

staging manual. CA Cancer J Clin. 2017;67(2):138-155. doi:10.3322/caac.21390

Downloads

Published

2025-12-25

How to Cite

Shrasti Singh, Dr. Nalini K. Sahoo, Mr. Akhilesh Kumar. (2025). POTENTIAL ROLE OF SYZYGIUM CUMINI EXTRACT SUPPRESSING A549 LUNG CARCINOMA CELL GROWTH. International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 4712–4725. Retrieved from https://ijprt.org/index.php/pub/article/view/1681

Issue

Vol. 15 No. 2 (2025)

Section

Research Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.